Coherus Biosciences Inc. (CHRS)
Market Closed
17 Jul, 20:00
$
1. 40
+0.01
+0.7194%
$
177.49M Market Cap
- P/E Ratio
- Div Yield
575,800 Volume
-2.02 Eps
$ 1.39
Previous Close 
Want to track CHRS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Coherus Biosciences Inc. (CHRS) Statistics
Valuation metrics
Market Cap 177.49M
Enterprise value 110.51M
Trailing P/E (ttm) -1.09
Forward P/E -
PEG ratio 0.05
Price/Sales (ttm) 3.66
Price/Book (mrq) 2.43
Enterprise Value/Revenue 2.36
Enterprise Value/EBITDA -0.69
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 567.92K
Average volume (90 days) 1.2M
Price summary
52-Week low 0.81
52-Week high 2.62
Beta -
50-Day moving average 1.5
200-Day moving average 1.73
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.23%
Operating margin -3.62%
Operational effectiveness
Return on assets -0.57%
Return on equity -1.75%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.34
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.11
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.22
Total debt (mrq) -
Total Debt/Equity (mrq) 0.69
Current ratio (mrq) 1.56%
Book value per share (mrq) 0.58
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
